You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Cholesterol 24S-hydroxylase inhibitor

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Atherosclerosis in Rheumatoid Arthritis and Lupus: Restoring

Recruiting
  • Rheumatoid Arthritis
    • Mineola, New York
      Winthrop University Hospital
    Apr 25, 2022

    Type 2 Diabetes Trial in China (Insulin glargine/Lixisenatide, IDegAsp, Metformin)

    Recruiting
    • Type 2 Diabetes Mellitus
    • Insulin glargine/Lixisenatide
    • +3 more
    • Baotou, China
    • +19 more
    Jul 11, 2022

    Congenital Adrenal Hyperplasia Trial in United States (Abiraterone acetate, Placebo, Hydrocortisone)

    Withdrawn
    • Congenital Adrenal Hyperplasia
    • Abiraterone acetate
    • +3 more
    • Los Angeles, California
    • +3 more
    Jan 30, 2023

    Alzheimer, Early Onset Trial in Beachwood (Sustiva Pill)

    Completed
    • Alzheimer Disease, Early Onset
    • Sustiva Pill
    • Beachwood, Ohio
      University Hospitals Brain Health and Memory Center
    Jan 28, 2022

    Alzheimer Trial in Worldwide (neflamapimod, )

    Completed
    Has Results
    • Alzheimer Disease
    • Long Beach, California
    • +37 more
    Sep 28, 2021

    Coronary Artery Bypass Trial in Beijing (Roxadustat, Placebo)

    Recruiting
    • Coronary Artery Bypass
    • Beijing, Beijing, China
    • +1 more
    Apr 18, 2022

    Hypercholesterolemia, Familial Hypercholesterolemia Trial (MK-0616, Placebo)

    Not yet recruiting
    • Hypercholesterolemia
    • Familial Hypercholesterolemia
    • (no location specified)
    Jul 10, 2023

    Hypercholesterolemia, Familial Hypercholesterolemia Trial (MK-0616, Placebo)

    Not yet recruiting
    • Hypercholesterolemia
    • Familial Hypercholesterolemia
    • (no location specified)
    Jul 10, 2023

    Healthy Trial (Mango, vanilla wafers)

    Not yet recruiting
    • Healthy
    • Mango
    • vanilla wafers
    • (no location specified)
    Sep 7, 2023

    Brain Cancer, Brain Tumor, Glioma Trial in Canada, United States (DNX-2401, pembrolizumab)

    Completed
    • Brain Cancer
    • +10 more
    • DNX-2401
    • pembrolizumab
    • Little Rock, Arkansas
    • +14 more
    Jul 13, 2021

    Congenital Adrenal Hyperplasia Trial in United States (Abiraterone acetate)

    Active, not recruiting
    • Congenital Adrenal Hyperplasia
    • Abiraterone acetate
    • Los Angeles, California
    • +3 more
    Feb 22, 2022

    ST Elevation Myocardial Infarction (STEMI) Trial (Rosuvastatin 20 mg, Evolocumab 140 mg/1 ml Subcutaneous Solution [REPATHA])

    Not yet recruiting
    • ST Elevation Myocardial Infarction (STEMI)
    • Rosuvastatin 20 mg
    • Evolocumab 140 mg/1 ml Subcutaneous Solution [REPATHA]
    • (no location specified)
    Feb 1, 2023

    HIV Trial in Daytona Beach (CPT31, Placebo)

    Completed
    • HIV Infections
    • Daytona Beach, Florida
      Covance Clinical Research Unit Inc.
    Mar 10, 2022

    Anemia in Dialysis-dependent CKD Patients Trial in Alexandria (Roxadustat)

    Recruiting
    • Anemia in Dialysis-dependent CKD Patients
    • Alexandria, Egypt
      Alexandria University
    Oct 29, 2023

    Atheroscleroses, Coronary Trial in Seoul (Rosuvastatin and Ezetimibe, Rosuvastatin)

    Active, not recruiting
    • Atheroscleroses, Coronary
    • Seoul, Korea, Republic of
    • +1 more
    Oct 1, 2022

    Diabetes, Cellular Senescence, Sodium-Glucose Transporter 2 Inhibitors Trial in Seoul (SGLT2 inhibitor, Glimepiride)

    Not yet recruiting
    • Diabetes Mellitus
    • +2 more
    • Seoul, Korea, Republic of
      Yonsei University College of Medicine
    Aug 1, 2023

    Natural History Study of Patients With Excess Androgen

    Recruiting
    • Congenital Adrenal Hyperplasia (CAH)
    • Familial Male-Limited Precocious Puberty (FMPP)
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 25, 2023

      Monitor Plasma Levels of 24OHC in Subject With HD

      Unknown status
      • Huntington Disease
      • Brain MRI
      • Milano, Italy
        UOC Genetica Medica e Neurogenetica
      Feb 9, 2021

      Hypercholesterolemia, Familial Hypercholesterolemia Trial in Worldwide (MK-0616, Placebo)

      Active, not recruiting
      • Hypercholesterolemia
      • Familial Hypercholesterolemia
      • Beverly Hills, California
      • +62 more
      Aug 2, 2022

      15q Duplication Syndrome, CDKL5 Deficiency Disease Trial in United States (Soticlestat)

      Completed
      Has Results
      • 15q Duplication Syndrome
      • CDKL5 Deficiency Disease
      • Los Angeles, California
      • +7 more
      May 24, 2022

      Hereditary Spastic Paraplegia Type 5 Trial in Fuzhou (evolocumab)

      Recruiting
      • Hereditary Spastic Paraplegia Type 5
      • Fuzhou, China
        Department of Neurology , First Affiliated Hospital Fujian Medic
      Nov 21, 2021

      ASCVD, Atherosclerotic Cardiovascular Disease, Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Trial (Evolocumab,

      Not yet recruiting
      • ASCVD
      • +3 more
      • (no location specified)
      Aug 3, 2023

      Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Locally Advanced Breast Carcinoma Trial in

      Not yet recruiting
      • Anatomic Stage III Breast Cancer AJCC v8
      • +14 more
      • Biopsy
      • +25 more
      • Portland, Oregon
        OHSU Knight Cancer Institute
      Jul 12, 2022

      Human Thyroid and Iodine Resistance

      Recruiting
      • Thyroid Cancer
      • Metabolites dosage
      • Toulouse, France
        Institut Claudius regaud IUCT Oncopole
      Dec 22, 2022

      Primary Hypercholesterolemia or Mixed Dyslipidemia Trial (Inclisiran, Matching Placebo for Inclisiran)

      Not yet recruiting
      • Primary Hypercholesterolemia or Mixed Dyslipidemia
      • (no location specified)
      May 24, 2023